BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 877580)

  • 1. Phenylketonuria: a new method for the simultaneous determination of plasma phenylalanine and tyrosine.
    Shen RS; Abell CW
    Science; 1977 Aug; 197(4304):665-7. PubMed ID: 877580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An enzymatic assay of plasma phenylalanine and tyrosine for the detection and management of phenylketonuria.
    Shen RS; Richardson CJ; Rouse BM; Abell CW
    Biochem Med; 1981 Oct; 26(2):211-21. PubMed ID: 7317039
    [No Abstract]   [Full Text] [Related]  

  • 3. A microplate-based enzymatic assay for the simultaneous determination of phenylalanine and tyrosine in serum.
    Wibrand F
    Clin Chim Acta; 2004 Sep; 347(1-2):89-96. PubMed ID: 15313145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid-chromatographic direct determination of phenylalanine and tyrosine in serum or plasma, with application to patients with phenylketonuria.
    Hilton MA
    Clin Chem; 1982 May; 28(5):1215-8. PubMed ID: 7074908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of heterozygotes for phenylketonuria. Total body phenylalanine clearance and concentrations of phenylalanine and tyrosine in the plasms of fasting subjects compared.
    Jagenburg R; Regårdh CG; Rödjer S
    Clin Chem; 1977 Sep; 23(9):1654-60. PubMed ID: 890909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of aromatic amino acids by ion-pair reversed-phase liquid chromatography in human sera from healthy and phenylketonuric individuals.
    Kalghatgi K; Ambrus CM; Horvath C; Karakousis CP; Sharma SD; Barren E
    Res Commun Chem Pathol Pharmacol; 1984 Aug; 45(2):253-9. PubMed ID: 6484311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic control of phenylalanine intake in phenylketonuria.
    Hoskins JA; Jack G; Wade HE; Peiris RJ; Wright EC; Starr DJ; Stern J
    Lancet; 1980 Feb; 1(8165):392-4. PubMed ID: 6101846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An extracorporeal hollow-fiber reactor for phenylketonuria using immobilized phenylalanine ammonia lyase.
    Larue C; Munnich A; Charpentier C; Saudubray JM; Frézal J; Rémy MH; Rivat C
    Dev Pharmacol Ther; 1986; 9(2):73-81. PubMed ID: 3956347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial.
    Longo N; Harding CO; Burton BK; Grange DK; Vockley J; Wasserstein M; Rice GM; Dorenbaum A; Neuenburg JK; Musson DG; Gu Z; Sile S
    Lancet; 2014 Jul; 384(9937):37-44. PubMed ID: 24743000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous measurement of phenylalanine and tyrosine in phenylketonuric plasma and dried blood by high-performance liquid chromatography.
    Dale Y; Mackey V; Mushi R; Nyanda A; Maleque M; Ike J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 May; 788(1):1-8. PubMed ID: 12668065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis of 15NL-phenylalanine by phenylalanine ammonia-lyase from Rhodotorula glutinis.
    Wang W; Yue H; Yuan Q; Wang W
    Amino Acids; 2009 Feb; 36(2):231-3. PubMed ID: 18365131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria.
    Ambrus CM; Anthone S; Horvath C; Kalghatgi K; Lele AS; Eapen G; Ambrus JL; Ryan AJ; Li P
    Ann Intern Med; 1987 Apr; 106(4):531-7. PubMed ID: 3826953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantage of phenylalanine to tyrosine ratio for the early detection of phenylketonuria.
    Levy PA; Miller JB; Shapira E
    Clin Chim Acta; 1998 Feb; 270(2):177-81. PubMed ID: 9544454
    [No Abstract]   [Full Text] [Related]  

  • 15. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L; Chang TM
    Biochim Biophys Acta; 1986 Oct; 883(3):432-8. PubMed ID: 3756210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.
    De Groot CJ; Hommes FA
    Enzyme; 1982; 28(4):404-7. PubMed ID: 7151779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro study.
    Ambrus CM; Horváth C; Kalghatgi K; Clowsley M; Huzella C; Warner R; Ambrus JL; Cooley CM; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):105-11. PubMed ID: 7122995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry.
    Chace DH; Millington DS; Terada N; Kahler SG; Roe CR; Hofman LF
    Clin Chem; 1993 Jan; 39(1):66-71. PubMed ID: 8419060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopterin derivatives in normal and phenylketonuric patients after oral loads of L-phenylalanine, L-tyrosine, and L-tryptophan.
    Leeming RJ; Blair JA; Green A; Raine DN
    Arch Dis Child; 1976 Oct; 51(10):771-7. PubMed ID: 1008581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood phenylalanine estimation for the patient with phenylketonuria using a portable device.
    Peterson K; Slover R; Gass S; Seltzer WK; McCabe LL; McCabe ER
    Biochem Med Metab Biol; 1988 Feb; 39(1):98-104. PubMed ID: 3355720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.